Kerala HC Case on Breast Cancer Drug Access Listed 57 Times Without Hearing

breast cancer Ribociclib Kerala High Court

Hızlı Bakış

A Kerala High Court case seeking access to life-saving breast cancer drug Ribociclib, filed in 2022, has been listed 57 times without a hearing.
The petitioner died during the case, which the court continued suo motu due to public interest.
A working group has urged the Chief Justice of India to expedite the hearing.

Yapay zekâ özeti

Yazı boyutu

A Kerala High Court case seeking access to life-saving breast cancer drug Ribociclib, filed in 2022, has been listed 57 times without a hearing. The petitioner died during the case, which the court continued suo motu due to public interest. A working group has urged the Chief Justice of India to expedite the hearing.

Tam haberi Times of India sitesinde oku

İlgili Konular

breast cancer

KonularRibociclib Kerala High Court judicial delays access to medicines patent law government use license

Bu haber ilk olarak şurada yayınlandı: Times of India.

İlgili Haberler

Bu konuda daha fazlabreast cancer

Law·21 sa önce

Solicitor General Tushar Mehta: Hindu Law Not Based on Manusmriti, But Mitakshara

Solicitor General Tushar Mehta stated that Hindu law is largely based on the 'Mitakshara' school of thought, derived from 'Yajnavalkya Smriti', not 'Manusmriti'. He explained that 'Mitakshara' is prevalent across most of India, except Assam and Bengal, which follow the 'Dayabhaga' school.

Times of India

Law·1 g önce

Understanding India's Diverse Land Records: From 7/12 Extract to Patta

India's land records, crucial for property transactions, vary in name and format across states due to land being a state subject. Documents like Maharashtra's 7/12 extract, Karnataka's Khata, Tamil Nadu's Patta, and Punjab's Jamabandi all serve to establish ownership and cultivation rights, with digitization efforts making them increasingly accessible online.

Times of India

Gelişiyor·1 g önce

Supreme Court Slams Delhi HC Trial Speed as Snail-Paced

The Supreme Court criticized the Delhi High Court's slow pace in a commercial suit filed in 2015, stating "even a snail may question the speed." The court rejected a plea by Levitate Mobile Technologies Pvt Ltd to add documents against Standard Chartered Bank, citing delays and similar prior applications.

Times of India

Gelişiyor·1 g önce

Delhi High Court Refuses to Stay Google's Trademark Infringement Ruling

The Delhi High Court division bench denied Google's request to stay a judgment finding it liable for trademark infringement against Hindware. The court noted potential confusion from displaying competitor websites and scheduled Google's appeal for July 24.

Economic Times

Gelişiyor·2 g önce

Petitioner Creates Ruckus in Supreme Court, Uses Abusive Language Against CJI

A petitioner in the Supreme Court of India caused a disturbance during a hearing on Friday, throwing papers and allegedly using abusive language against the Chief Justice of India. Security personnel escorted the individual out, but the court decided not to take further action, dismissing the appeal.

Times of India

Gelişiyor·2 g önce

Canadians Eligible for Up to $300,000 in Class-Action Settlement Over Recalled Plant Milk

Canadians who bought or consumed recalled Silk and Great Value plant-based beverages linked to a listeria outbreak can claim up to C$300,000 under a C$7.5 million class-action settlement approved by the Superior Court of Quebec. Claims are open until October 16, 2026.

Times of India

Bu konuda daha fazlabreast cancer